These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


392 related items for PubMed ID: 16084942

  • 1. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
    Tong GX, Yee H, Chiriboga L, Hernandez O, Waisman J.
    Hum Pathol; 2005 Jul; 36(7):741-6. PubMed ID: 16084942
    [Abstract] [Full Text] [Related]

  • 2. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
    Soukup V, Babjuk M, Dusková J, Pesl M, Szakáczová M, Zámecník L, Dvorácek J.
    Urol Int; 2008 Jul; 80(4):413-8. PubMed ID: 18587253
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF, Epstein JI.
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
    Yin H, Leong AS.
    Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
    Cox RM, Schneider AG, Sangoi AR, Clingan WJ, Gokden N, McKenney JK.
    Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
    [Abstract] [Full Text] [Related]

  • 14. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [Abstract] [Full Text] [Related]

  • 15. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
    Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W, Niu Y, Yang Z, Shen Z, Li E.
    J Clin Pathol; 2006 Sep 01; 59(9):958-64. PubMed ID: 16524962
    [Abstract] [Full Text] [Related]

  • 16. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
    Wen YH, Yee H, Goswami S, Shukla PS.
    Int J Gynecol Pathol; 2009 Mar 01; 28(2):187-92. PubMed ID: 19188814
    [Abstract] [Full Text] [Related]

  • 17. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D, Stenzinger A, Klauschen F, Stephan C, Jung K, Erbersdobler A, Rabien A.
    Pathobiology; 2011 Mar 01; 78(3):123-31. PubMed ID: 21613799
    [Abstract] [Full Text] [Related]

  • 18. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
    McKenney JK, Amin MB, Young RH.
    Mod Pathol; 2003 Jul 01; 16(7):623-9. PubMed ID: 12861056
    [Abstract] [Full Text] [Related]

  • 19. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
    Ross JS, del Rosario AD, Bui HX, Kallakury BV, Okby NT, Figge J.
    Mod Pathol; 1996 Aug 01; 9(8):854-60. PubMed ID: 8871928
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.